Jenthera Therapeutics
Montréal, Quebec, Canada
About Jenthera Therapeutics
Jenthera Therapeutics is a developer of a cell-targeted nuclease drug that provides precision gene alteration. The business's platform provides a cutting-edge cell-targeted nuclease approach for therapeutics that addresses the fundamental problems with CRISPR-based gene editing and gives healthcare clients products that are immunogenic, secure, and affordable.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Funding stage: Seed
- Last round: Pre-Seed (Jun 2020)
- Website: jenthera.com
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/jenthera-therapeutics-2473470 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.